From GlobeNewswire: 2025-05-21 07:05:00

Clearside Biomedical, Inc. will be participating in a fireside chat at the Stifel 2025 Virtual Ophthalmology Forum on May 27, 2025, at 9:00 a.m. ET. The company is focused on revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space to improve patient outcomes. Their SCS injection platform allows for targeted and compartmentalized delivery of various therapies to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing a pipeline of small molecule product candidates, with their lead program, CLS-AX, in development for the treatment of neovascular age-related macular degeneration.



Read more at GlobeNewswire: Clearside Biomedical to Participate in a Fireside Chat at